Table Of Content

Toxicology 111 (1996) 349-350 Volume contents Volume 111 (1996) Special Issue: RISK ASSESSMENT ISSUES FOR SENSITIVE HUMAN POPULATIONS Conference Proceedings, Wright-Patterson AFB, OH (April 25—27, 1995) Preface Introduction— Summary of the Conference on Risk Assesment Issues for Sensitive Human Populations J.M. Frazier, D.R. Mattie, W.B. Peirano (USA), Session I. BIOLOGICAL VARIABILITY IN RISK ASSESSMENT FOR HUMAN POPULATIONS Human interindividual variability in susceptibility to toxic effects: from annoying detail to a central determinant of risk D. Hattis (USA) Kids are different: developmental variability in toxicology L.J. Graeter, M.E. Mortensen (USA) Quantitative cancer assessment for vinyl chloride: indications of early-life sensitivity V.J. Cogliano, G.F.S. Hiatt, A.D en (USA) Efficient tissue repair underlies the resiliency of postnatally developing rats to chlordeco+nC Cel , hepatotoxicity A. Dalu, H.M. Mehendale (USA). Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways S.A. McFadden (USA), Session II. MULTIPLE CHEMICAL SENSITIVITY: CLINICAL, EXPERIMENTAL, AND THEORETICAL CONSIDERATIONS Chemical sensitivity: symptom, syndrome or mechanism for disease? C.S. Miller (USA) Sensitization induced by kindling and kindling-related phenomena as a model for Multiple Chemical Sensitivity J. Rossi Il] (USA). Clinically relevant EEG studies and psychophysiological findings: possible neural mechanisms for multiple chemical sensitivity I.R. Bell (USA) 101-117 Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity D.H. Overstreet, C.S. Miller, D.S. Janowsky, R.W. Russell (USA) 119-134 Proposed animal neurosensitization model for multiple chemical sensitivity in studies with formalin B.A. Sorg, J.R. Willis, T.-C. Nowatka, C. Ulibarri, R.E. See, H.H. Westberg (USA) 135-145 Session Ill. RESPONSES OF SPECIAL HUMAN SUBPOPULATIONS TO TOXICANTS Adverse health effects of air pollutants in a nonsmoking population C.A. Pope III (USA) 149-155 Comparison of four human studies of perinatal exposure to methylmercury for use in risk assessment J.L. Cicmanec (USA), 157-162 Role of nutrition in the survival after hepatotoxic injury S. Chanda, H.M. Mehendale (USA) 163-178 350 Volume contents /T oxicology 111 (1996) 349-350 Session IV. OCCUPATIONAL AND ENVIRONMENTAL EXPOSURE CASE STUDIES Overview of diisocyanate occupational asthma J.A. Bernstein (USA) 181-189 Characterization of histamine releasing factors in diisocyanate-induced occupational asthma Z.L. Lummus, R. Alam, J.A. Bernstein, D.I. Bernstein (USA) 191-206 Development and application of non-invasive biomarkers for carcinogen-DNA adduct analysis in occupationally exposed populations G. Talaska, J. Cudnik, M. Jaeger, N. Rothman, R. Hayes, V.J. Bhatnagar, S.J. Kayshup (USA, India) 207-212 Possible health risks from low level exposure to beryllium A.W. Stange, D.E. Hilmas, F.J. Furman (USA) 213-224 Sampling and analysis of airborne resin acids and solvent-soluble material derived from heated colophony (rosin) flux: a method to quantify exposure to sensitizing compounds liberated during electronics soldering P.A. Smith, P.S. Son, P.M. Callaghan, W.W. Jederberg, K. Kuhlmann, K.R. Still (USA) 225-238 Exposure-response functions in Air Force toxic risk modeling L.L. Philipson, J.M. Hudson, A.M. See (USA) 239-249 Session V. INCORPORATING SUSCEPTIBILITY INTO RISK ASSESSMENT Obtaining information about susceptibility from the epidemiological literature J.A. Grassman (USA) 253-270 Evaluating human variability in chemical risk assessment: hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene H.A. Barton, C.D. Flemming, J.C. Lipscomb (USA) 271-287 Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform B.C. Allen, T.R. Covington, H.J. Clewell (USA) 289-303 Risk assessment policy for evaluating reproductive system toxicants and the impact of responses on sensitive populations G.B. Briggs (USA) 305-313 Use of physiologically based pharmacokinetic modeling to investigate individual versus population risk H.J. Clewell II], M.E. Andersen (USA) 315-329 Interindividual variations in susceptibility and sensitivity: linking risk assessment and risk management R.J. Preston (USA) 331-341 Author Index 343 Subject Index 345-348 Volume Contents. 349-350 © The paper used in this publication meets the requirements of ANSI/NISO 239.48-1992 (Permanence of Paper)